Laser therapy to treat early stage breast cancer.
Columbia University Medical Center is now enrolling patients in a new clinical trial examining the effectiveness of laser therapy to treat early-stage breast cancer. This new research is testing a non-surgical treatment called Novilase® Interstitial Laser Therapy (ILT).
The study will test the ability of the laser to ablate (destroy) breast cancers that are equal to or less than 2 centimeters in size. Approximately 50% of breast cancer patients are estimated to qualify for inclusion in the study.
Traditionally, early-stage breast cancers have been removed by surgery, i.e., lumpectomy, which can unfavorably affect the look and feel of the breast. Destroying the tumor with a laser may have advantages including:
Less chance of infection,
Much shorter recovery time,
Preservation of natural shape (i.e., cosmetic appearance) and feel of the breast